自身免疫性肝炎诱发因素研究进展

doi:10.3969/j.issn.1672-5069.2018.06.040

摘要/Abstract

摘要： 自身免疫性肝炎是一种由针对肝细胞的自身免疫反应所介导的肝脏实质性炎症。各种因素能诱导自身免疫性肝炎的发生发展,目前认识的主要诱导因素有药物、感染、环境、年龄、性别、遗传等,但诱导机制仍不十分清楚。了解诱导因素可对防治疾病有帮助。

关键词: 自身免疫性肝炎, 诱导因素, 发病机制

Abstract: Autoimmune hepatitis is a parenchymal inflammation of liver that is mediated by autoimmune response to hepatocytes. There are various factors which can induce autoimmune hepatitis such as drugs,infection,environment,age,gender and genetic factors. However,the mechanism of induction is still not yet very clear,and the illumination of these factors might help prevent and manage the disease. In this review,we will do a brief overview of each of the above mentioned induction factors.

Key words: Autoimmune hepatitis, Predisposing factors, Mechanism

夏庚综述, 祁飞, 杨晋辉审校. 自身免疫性肝炎诱发因素研究进展[J]. 实用肝脏病杂志, 2018, 21(6): 983-986.

Xia Geng, Qi Fei, Yang Jinhui.. Predisposing factors to autoimmune hepatitis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 983-986.

参考文献

[1] Krawitt EL.Autoimmune hepatitis. N Engl J Med,2006,354(1):54-66.
[2] Björnsson E,Talwalkar J,Treeprasertsuk S,et al.Drug-induced autoimmune hepatitis:clinical characteristics and prognosis. Hepatology,2010,51(6):2040-2048.
[3] Heurque A,Bernard-Chabert B, Diebold M,et al.Drug induced autoimmune hepatitis: a frequent disorder. Gut,2007,56:A271.
[4] Zapata E,Castiella A,Otazua P.Hepatitis autoinmmune en Gipuzkoa,Pais Vasco: epidemiologia,indices diagnosticos e impacto de la edad en lahistologia. Rev Esp Enterm Digest,2011,103(1):137-138.
[5] Mieli-Vergani G,Vergani D.Autoimmune hepatitis. Nat Rev Gastroenterol Hepatol,2011,8(6):320-329.
[6] Liu ZX,kaplowitz N. Immune-mediated drug-induced liver disease. Clin Liver Dis,2002,6(3):755-774.
[7] Beaune PH,Lecoeur S,Bourdi M,et al.Anti-cytochrome P450 autoantibodies in drug-induced disease. Eur J Haematol Suppl,1996,60:89-92.
[8] Shear NH,Spielberg SP.Anticonvulsant hypersensitivity syndrome,In vitro assessment of risk. Clin Invest,1988,82(6):1826-1832.
[9] Rieder MJ,Uetrecht J,Shear NH, et al.Diagnosis of sulfonamide hypersensitivity reactions by“in Vitro” rechallenge with hydroxylamine metabolites. Ann Intern Med,1989,110(4):286-289.
[10] Czaja AJ.Drug-induced autoimmune-like hepatitis. Dig Dis Sci,2011,56(4):958-976.
[11] Chalasani N,Bjornsson E.Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology,2010,138(7):2246-2259.
[12] Longhi MS,Ma Y,Mieli-Vergani G,et al.Aetiopathogenesis of autoimmune hepatitis. J Autoimmun,2010,34(1):7-14.
[13] Vergani D,Choudhuri K,Bogdanos DP,et al.Pathogenesis of autoimmune hepatitis. Clin Liver Dis,2002,6(3):439-449.
[14] Vergani D,Mieli-Vergani G.Aetiopathogenesis of autoimmune hepatitis. World J Gastroenterol,2008,14(21):3306-3312.
[15] Posnett DN.Herpesviruses and autoimmunity. Curr Opin Investig Drugs,2008,9(5):505-514.
[16] Toussirot E,Roudier J.Epstein-Barr virus in autoimmune diseases. Best practice and research. Clin Rheumatol,2008,22(5):883-896.
[17] Smyk DS1,Bogdanos DP,Kriese S,et al. Urinary tract infection as a risk factor for autoimmune liver disease:From bench to bedside. Clin Res Hepatol Gastroenterol,2012,36(2):110-121.
[18] Baum H.Mitochondrial antigens,molecular mimicry and autoimmune disease. Biochim Biophys Acta,1995,1271(1):111-121.
[19] Smyk D,Rigopoulou EI, Baum H. Autoimmunity and environment: Am I at risk Clinic Rev Allerg Immunol,2012,42(2):199-212.
[20] Leslie RD,Hawa M.Twin studies in autoimmune disease. Acta Genet Med Gemellol Roma,1994,43(1-2):71-81.
[21] Selmi C,Mayo MJ,Bach N,et al.Primary biliary cirrhosis in monozygotic and dizygotic twins:genetics,epigenetics,and environment. Gastroenterology,2004,127(2):485-492.
[22] Cooper GS,Wither J,Bernatsky S,et al.Occupational and environmental exposures and risk of systemic lupus erythematosus:silica,sunlight,solvents. Rheumatology(Oxford),2010,49(11):2172-2180.
[23] Ngo ST,Steyn FJ,McCombe PA. Gender differences in autoimmune disease. Clin Rheumatol,2014,35(3):347-369.
[24] Jarvinen P,Aho K.Twin studies in rheumatic diseases. Semin Arthritis Rheum,1994,24(1):19-28.
[25] Parks CG,Conrad K,Cooper GS.Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect,1999,107(5):793-802.
[26] Pfau JC,Brown JM,Holian A.Silica-exposed mice generate autoantibodies to apoptotic cells. Toxicology,2004,195(2-3):167-176.
[27] Brown JM,Archer AJ,Pfau JC,et al.Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice. Clin Exp Immunol,2003,131(3):415-421.
[28] Parks CG,Cooper GS.Occupational exposures and risk of systemic lupus erythematosus:a review of the evidence and exposure assessment methods in population-and clinic-based studies. Lupus,2006,15(11):728-736.
[29] Rider V,Li X,Peterson G,et al.Differential expression of estrogen receptors in women with systemic lupus erythematosus. J Rheumatol,2006,33(6):1093-1101.
[30] Keating JJ,O’Brien CJ,Stellon AJ,et al. Influence of aetiology,clinical and histological features on survival in chronic active hepatitis:an analysis of 204 patients. Q J Med,1987,62(237):59-66.
[31] Peng M,Li Y,Zhang M,et al.Clinical features in different age groups of patients with autoimmune hepatitis. Exp Ther Med,2014,7(1):145-148.
[32] Maggiore G,Veber F,Bernard O,et al.Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents. J Pediatr Gastroenterol Nutr,1993,17(4):376-381.
[33] Gregorio GV,Portmann B,Reid F,et al.Autoimmune hepatitis in childhood:a 20-year experience. Hepatology,1997,25(3):541-547.
[34] Czaja AJ,Carpenter HA.Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly. Hepatology,2006,43(3):532-538.
[35] Al-Chalabi T,Boccato S,Portmann BC,et al.Autoimmune hepatitis (AIH) in the elderly:a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. Hepatology,2006,45(4):575-583.
[36] 中华医学会肝病学分会、消化病学分会、感染病学分会. 胆汁淤积性肝病诊断和治疗共识(2015).实用肝脏病杂志,2016,19(6):Ⅰ-ⅩⅠ.
[37] Ngu JH,Gearry RB,Frampton CM,et al.Predictors of poor outcome in patients with autoimmune hepatitis:A population based study. Hepatology,2013,57(6):2399-2406.
[38] Amur S,Parekh A,Mummaneni P.Sex differences and genomics in autoimmune diseases. J Autoimmun,2012,38(2-3):254-265.
[39] Al-Chalabi T,Underhill JA,Portmann BC,et al.Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. J Hepatol,2008,48(1):140-147.
[40] Shoenfeld Y,Angela Tincani M,Gershwin E.Sex gender and autoimmunity. J Autoimmun,2012,38(2-3):71-J73.
[41] Lleo A,Battezzati PM,Selmi C,et al. Is autoimmunity a matter of sex Autoimmun Rev,2008,7(8):626-630.
[42] Ozcelik T.X chromosome inactivation and female predisposition to auto-immunity. Clin Rev Allerg Immu,2008,34(3):348-351.
[43] Selmi C.The X in sex: how autoimmune diseases revolve around sex chromosomes. Best Pract Res CL Rh,2008,22(5):913-922.
[44] Manns MP,Kruger M.Immunogenetics of chronic liver diseases. Gastroenterology,1994,106(6):1676-1697.
[45] Doherty DG,Donaldson PT,Underhill JA,et al.Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology,1994,19(3):609-615.
[46] Vazquez-Garcia MN,Alaez C,Olivo A,et al.MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis. J Hepatol,1998,28(6):985-990.